Collection spotlight

Best Healthcare Stocks

Quality leaders in Healthcare ranked by capital efficiency and balance sheet strength.

  • ROIC ≥ 8.0%
  • Debt/Equity ≤ 2.00x

Stock ideas

Stocks for best healthcare stocks

  1. Solara Active Pharma Sciences Limited SOLARA.NS Healthcare
    $597.40

    ROIC: 680878.6% • Debt/Equity: 0.73x • Revenue growth: -8.2%

    ROIC
    680878.6%
    Debt/Equity
    0.73x
    Revenue growth
    -8.2%
  2. Elevance Health Inc. ELV Healthcare
    $371.37

    ROIC: 474.1% • Debt/Equity: 0.76x • Revenue growth: 11.9%

    ROIC
    474.1%
    Debt/Equity
    0.76x
    Revenue growth
    11.9%
  3. Ping An Healthcare and Technology Company Limited 1833.HK Healthcare
    $16.11

    ROIC: 401.8% • Debt/Equity: 0.01x • Revenue growth: -10.1%

    ROIC
    401.8%
    Debt/Equity
    0.01x
    Revenue growth
    -10.1%
  4. HealthCare Global Enterprises Limited HCG.NS Healthcare
    $734.45

    ROIC: 284.0% • Debt/Equity: 1.99x • Revenue growth: 15.7%

    ROIC
    284.0%
    Debt/Equity
    1.99x
    Revenue growth
    15.7%
  5. Novo Nordisk A/S NVO Healthcare
    $56.24

    ROIC: 76.2% • Debt/Equity: 0.72x • Revenue growth: 24.7%

    ROIC
    76.2%
    Debt/Equity
    0.72x
    Revenue growth
    24.7%
  6. Novo Nordisk A/S NOV.DE Healthcare
    $48.36

    ROIC: 76.2% • Debt/Equity: 0.72x • Revenue growth: 24.6%

    ROIC
    76.2%
    Debt/Equity
    0.72x
    Revenue growth
    24.6%
  7. Amvis Holdings, Inc. 7071.T Healthcare
    $461.00

    ROIC: 72.4% • Debt/Equity: 1.11x • Revenue growth: 32.8%

    ROIC
    72.4%
    Debt/Equity
    1.11x
    Revenue growth
    32.8%
  8. Alembic Pharmaceuticals Limited APLLTD.NS Healthcare
    $905.80

    ROIC: 64.8% • Debt/Equity: 0.24x • Revenue growth: 5.2%

    ROIC
    64.8%
    Debt/Equity
    0.24x
    Revenue growth
    5.2%
  9. Caplin Point Laboratories Limited CAPLIPOINT.NS Healthcare
    $1817.50

    ROIC: 60.9% • Debt/Equity: 0.00x • Revenue growth: 16.3%

    ROIC
    60.9%
    Debt/Equity
    0.00x
    Revenue growth
    16.3%
  10. Blue Jet Healthcare Limited BLUEJET.NS Healthcare
    $556.65

    ROIC: 53.0% • Debt/Equity: 0.02x • Revenue growth: 21.7%

    ROIC
    53.0%
    Debt/Equity
    0.02x
    Revenue growth
    21.7%
  11. Kangji Medical Holdings Limited 9997.HK Healthcare
    $9.20

    ROIC: 52.6% • Debt/Equity: 0.00x • Revenue growth: 12.6%

    ROIC
    52.6%
    Debt/Equity
    0.00x
    Revenue growth
    12.6%
  12. Dr. Lal PathLabs Limited LALPATHLAB.NS Healthcare
    $1476.20

    ROIC: 50.7% • Debt/Equity: 0.07x • Revenue growth: 12.2%

    ROIC
    50.7%
    Debt/Equity
    0.07x
    Revenue growth
    12.2%
  13. RemeGen Co., Ltd. 9995.HK Healthcare
    $85.65

    ROIC: 49.5% • Debt/Equity: 1.34x • Revenue growth: 0.0%

    ROIC
    49.5%
    Debt/Equity
    1.34x
    Revenue growth
    0.0%
  14. Hansoh Pharmaceutical Group Company Limited 3692.HK Healthcare
    $39.98

    ROIC: 48.9% • Debt/Equity: 0.00x • Revenue growth: 9.5%

    ROIC
    48.9%
    Debt/Equity
    0.00x
    Revenue growth
    9.5%
  15. Duality Biotherapeutics, Inc. 9606.HK Healthcare
    $343.00

    ROIC: 48.2% • Debt/Equity: -0.00x • Revenue growth: 557.8%

    ROIC
    48.2%
    Debt/Equity
    -0.00x
    Revenue growth
    557.8%
  16. Torrent Pharmaceuticals Limited TORNTPHARM.NS Healthcare
    $3822.10

    ROIC: 47.7% • Debt/Equity: 0.42x • Revenue growth: 9.6%

    ROIC
    47.7%
    Debt/Equity
    0.42x
    Revenue growth
    9.6%
  17. Dr. Agarwal's Health Care Limited AGARWALEYE.NS Healthcare
    $491.15

    ROIC: 46.9% • Debt/Equity: 0.51x • Revenue growth: 39.5%

    ROIC
    46.9%
    Debt/Equity
    0.51x
    Revenue growth
    39.5%
  18. Fortis Healthcare Limited FORTIS.NS Healthcare
    $946.50

    ROIC: 45.8% • Debt/Equity: 0.28x • Revenue growth: 18.6%

    ROIC
    45.8%
    Debt/Equity
    0.28x
    Revenue growth
    18.6%
  19. TAUNS Laboratories, Inc. 197A.T Healthcare
    $510.00

    ROIC: 45.3% • Debt/Equity: 0.83x • Revenue growth: 2.0%

    ROIC
    45.3%
    Debt/Equity
    0.83x
    Revenue growth
    2.0%
  20. Cohance Lifesciences Limited COHANCE.NS Healthcare
    $529.80

    ROIC: 45.3% • Debt/Equity: 0.16x • Revenue growth: 6.0%

    ROIC
    45.3%
    Debt/Equity
    0.16x
    Revenue growth
    6.0%
  21. Piramal Pharma Limited PPLPHARMA.NS Healthcare
    $184.20

    ROIC: 43.8% • Debt/Equity: 0.60x • Revenue growth: 9.0%

    ROIC
    43.8%
    Debt/Equity
    0.60x
    Revenue growth
    9.0%
  22. Piramal Pharma Limited PPLPHARMA.BO Healthcare
    $171.35

    ROIC: 43.8% • Debt/Equity: 0.60x • Revenue growth: 9.0%

    ROIC
    43.8%
    Debt/Equity
    0.60x
    Revenue growth
    9.0%
  23. Gilead Sciences, Inc. GILD Healthcare
    $121.36

    ROIC: 43.3% • Debt/Equity: 1.38x • Revenue growth: 4.2%

    ROIC
    43.3%
    Debt/Equity
    1.38x
    Revenue growth
    4.2%
  24. Metropolis Healthcare Limited METROPOLIS.BO Healthcare
    $1929.40

    ROIC: 41.9% • Debt/Equity: 0.15x • Revenue growth: 7.8%

    ROIC
    41.9%
    Debt/Equity
    0.15x
    Revenue growth
    7.8%
  25. Inventurus Knowledge Solutions Ltd. IKS.NS Healthcare
    $1736.30

    ROIC: 41.2% • Debt/Equity: 0.48x • Revenue growth: 48.9%

    ROIC
    41.2%
    Debt/Equity
    0.48x
    Revenue growth
    48.9%
  26. Inventurus Knowledge Solutions Ltd. IKS.BO Healthcare
    $1635.00

    ROIC: 41.2% • Debt/Equity: 0.48x • Revenue growth: 48.9%

    ROIC
    41.2%
    Debt/Equity
    0.48x
    Revenue growth
    48.9%
  27. HealthCare Global Enterprises Limited HCG.BO Healthcare
    $754.30

    ROIC: 40.7% • Debt/Equity: 1.99x • Revenue growth: 15.7%

    ROIC
    40.7%
    Debt/Equity
    1.99x
    Revenue growth
    15.7%
  28. Zydus Lifesciences Limited ZYDUSLIFE.NS Healthcare
    $915.05

    ROIC: 39.5% • Debt/Equity: 0.13x • Revenue growth: 13.3%

    ROIC
    39.5%
    Debt/Equity
    0.13x
    Revenue growth
    13.3%
  29. Cohance Lifesciences Limited COHANCE.BO Healthcare
    $581.05

    ROIC: 39.1% • Debt/Equity: 0.16x • Revenue growth: 7.3%

    ROIC
    39.1%
    Debt/Equity
    0.16x
    Revenue growth
    7.3%
  30. Alembic Pharmaceuticals Limited APLLTD.BO Healthcare
    $898.95

    ROIC: 38.9% • Debt/Equity: 0.24x • Revenue growth: 5.8%

    ROIC
    38.9%
    Debt/Equity
    0.24x
    Revenue growth
    5.8%
  31. Eris Lifesciences Limited ERIS.NS Healthcare
    $1498.80

    ROIC: 38.4% • Debt/Equity: 0.87x • Revenue growth: 25.1%

    ROIC
    38.4%
    Debt/Equity
    0.87x
    Revenue growth
    25.1%
  32. Poly Medicure Limited POLYMED.NS Healthcare
    $1817.10

    ROIC: 38.3% • Debt/Equity: 0.07x • Revenue growth: 17.6%

    ROIC
    38.3%
    Debt/Equity
    0.07x
    Revenue growth
    17.6%
  33. Kanamic Network Co.,LTD 3939.T Healthcare
    $533.00

    ROIC: 36.7% • Debt/Equity: 0.24x • Revenue growth: 29.0%

    ROIC
    36.7%
    Debt/Equity
    0.24x
    Revenue growth
    29.0%
  34. Aurobindo Pharma Limited AUROPHARMA.NS Healthcare
    $1257.10

    ROIC: 33.8% • Debt/Equity: 0.25x • Revenue growth: 6.8%

    ROIC
    33.8%
    Debt/Equity
    0.25x
    Revenue growth
    6.8%
  35. GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS Healthcare
    $2398.10

    ROIC: 33.5% • Debt/Equity: 0.01x • Revenue growth: 6.4%

    ROIC
    33.5%
    Debt/Equity
    0.01x
    Revenue growth
    6.4%
  36. Shaily Engineering Plastics Limited SHAILY.NS Healthcare
    $2368.10

    ROIC: 32.6% • Debt/Equity: 0.34x • Revenue growth: 19.8%

    ROIC
    32.6%
    Debt/Equity
    0.34x
    Revenue growth
    19.8%
  37. Rainbow Children's Medicare Limited RAINBOW.NS Healthcare
    $1375.30

    ROIC: 32.4% • Debt/Equity: 0.52x • Revenue growth: 21.9%

    ROIC
    32.4%
    Debt/Equity
    0.52x
    Revenue growth
    21.9%
  38. Ajanta Pharma Limited AJANTPHARM.NS Healthcare
    $2922.00

    ROIC: 31.3% • Debt/Equity: 0.01x • Revenue growth: 14.3%

    ROIC
    31.3%
    Debt/Equity
    0.01x
    Revenue growth
    14.3%
  39. NATCO Pharma Limited NATCOPHARM.NS Healthcare
    $954.55

    ROIC: 29.1% • Debt/Equity: 0.04x • Revenue growth: 23.8%

    ROIC
    29.1%
    Debt/Equity
    0.04x
    Revenue growth
    23.8%
  40. NATCO Pharma Limited NATCOPHARM.BO Healthcare
    $901.70

    ROIC: 29.1% • Debt/Equity: 0.04x • Revenue growth: 23.8%

    ROIC
    29.1%
    Debt/Equity
    0.04x
    Revenue growth
    23.8%
  41. Angelalign Technology Inc. 6699.HK Healthcare
    $65.15

    ROIC: 28.4% • Debt/Equity: 0.00x • Revenue growth: 25.5%

    ROIC
    28.4%
    Debt/Equity
    0.00x
    Revenue growth
    25.5%
  42. Fortis Healthcare Limited FORTIS.BO Healthcare
    $953.80

    ROIC: 27.3% • Debt/Equity: 0.28x • Revenue growth: 18.6%

    ROIC
    27.3%
    Debt/Equity
    0.28x
    Revenue growth
    18.6%
  43. Sun Pharmaceutical Industries Limited SUNPHARMA.NS Healthcare
    $1737.00

    ROIC: 27.1% • Debt/Equity: 0.03x • Revenue growth: 12.0%

    ROIC
    27.1%
    Debt/Equity
    0.03x
    Revenue growth
    12.0%
  44. JD Health International Inc. 6618.HK Healthcare
    $60.45

    ROIC: 26.8% • Debt/Equity: 0.00x • Revenue growth: 21.6%

    ROIC
    26.8%
    Debt/Equity
    0.00x
    Revenue growth
    21.6%
  45. Ipca Laboratories Limited IPCALAB.NS Healthcare
    $1421.70

    ROIC: 25.4% • Debt/Equity: 0.20x • Revenue growth: 13.5%

    ROIC
    25.4%
    Debt/Equity
    0.20x
    Revenue growth
    13.5%
  46. Ipca Laboratories Limited IPCALAB.BO Healthcare
    $1421.50

    ROIC: 25.4% • Debt/Equity: 0.20x • Revenue growth: 13.5%

    ROIC
    25.4%
    Debt/Equity
    0.20x
    Revenue growth
    13.5%
  47. Narayana Hrudayalaya Limited NH.BO Healthcare
    $1948.85

    ROIC: 25.0% • Debt/Equity: 0.67x • Revenue growth: 21.4%

    ROIC
    25.0%
    Debt/Equity
    0.67x
    Revenue growth
    21.4%
  48. Narayana Hrudayalaya Limited NH.NS Healthcare
    $1914.60

    ROIC: 25.0% • Debt/Equity: 0.67x • Revenue growth: 21.4%

    ROIC
    25.0%
    Debt/Equity
    0.67x
    Revenue growth
    21.4%
  49. United Therapeutics Corporation UTHR Healthcare
    $502.71

    ROIC: 24.9% • Debt/Equity: 0.05x • Revenue growth: 17.5%

    ROIC
    24.9%
    Debt/Equity
    0.05x
    Revenue growth
    17.5%
  50. Fisher & Paykel Healthcare Corporation Limited FPH.AX Healthcare
    $32.29

    ROIC: 24.0% • Debt/Equity: 0.08x • Revenue growth: -9.7%

    ROIC
    24.0%
    Debt/Equity
    0.08x
    Revenue growth
    -9.7%
  51. Divi's Laboratories Limited DIVISLAB.NS Healthcare
    $6360.50

    ROIC: 23.8% • Debt/Equity: 0.00x • Revenue growth: 9.2%

    ROIC
    23.8%
    Debt/Equity
    0.00x
    Revenue growth
    9.2%
  52. Cipla Limited CIPLA.NS Healthcare
    $1501.10

    ROIC: 23.7% • Debt/Equity: 0.01x • Revenue growth: 9.3%

    ROIC
    23.7%
    Debt/Equity
    0.01x
    Revenue growth
    9.3%
  53. Cipla Limited CIPLA.BO Healthcare
    $1495.65

    ROIC: 23.7% • Debt/Equity: 0.01x • Revenue growth: 9.3%

    ROIC
    23.7%
    Debt/Equity
    0.01x
    Revenue growth
    9.3%
  54. HOYA Corporation 7741.T Healthcare
    $25170.00

    ROIC: 23.4% • Debt/Equity: 0.04x • Revenue growth: 14.3%

    ROIC
    23.4%
    Debt/Equity
    0.04x
    Revenue growth
    14.3%
  55. M3, Inc. 2413.T Healthcare
    $2085.00

    ROIC: 23.1% • Debt/Equity: 0.06x • Revenue growth: 14.1%

    ROIC
    23.1%
    Debt/Equity
    0.06x
    Revenue growth
    14.1%
  56. Max Healthcare Institute Limited MAXHEALTH.NS Healthcare
    $1040.50

    ROIC: 22.7% • Debt/Equity: 0.32x • Revenue growth: 25.8%

    ROIC
    22.7%
    Debt/Equity
    0.32x
    Revenue growth
    25.8%
  57. Laurus Labs Limited LAURUSLABS.NS Healthcare
    $1135.00

    ROIC: 22.4% • Debt/Equity: 0.62x • Revenue growth: 4.6%

    ROIC
    22.4%
    Debt/Equity
    0.62x
    Revenue growth
    4.6%
  58. Laurus Labs Limited LAURUSLABS.BO Healthcare
    $1018.10

    ROIC: 22.4% • Debt/Equity: 0.62x • Revenue growth: 4.6%

    ROIC
    22.4%
    Debt/Equity
    0.62x
    Revenue growth
    4.6%
  59. Jubilant Pharmova Limited JUBLPHARMA.NS Healthcare
    $1072.80

    ROIC: 22.2% • Debt/Equity: 0.44x • Revenue growth: 15.9%

    ROIC
    22.2%
    Debt/Equity
    0.44x
    Revenue growth
    15.9%
  60. Gland Pharma Limited GLAND.NS Healthcare
    $1796.30

    ROIC: 22.1% • Debt/Equity: 0.03x • Revenue growth: 15.0%

    ROIC
    22.1%
    Debt/Equity
    0.03x
    Revenue growth
    15.0%

Collections

Pick a starting point

Dividend payers

Income-focused names with meaningful dividend yield and coverage.

High Compounders

Operators that consistently reinvest at high returns on capital.

Cash compounding

Businesses converting revenue into free cash flow with disciplined reinvestment.

Product

Watchlist Ideas Pricing

Company

Contact Terms Privacy

Stay in touch

support@marketdaddy.ai YouTube community

© 2025 Market Daddy. All rights reserved. Chamber of Commerce number: 97992496. Tax number: NL005301830B37.